SCHEMBL439379

SCHEMBL439379

O=C(O)N1CC=C(c2cccc(Br)n2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
ALOX15 P16050 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
HTR1A P08908 2/20 0.38
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
GRM1 Q13255 2/20 0.38
GRM5 P41594 1/20 0.38
MAPT P10636 3/20 0.38
KCNH2 Q12809 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
PRMT5 O14744 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31401477 0.84 JAK1 (0.51) ALDH1A1SMN1; SMN2ALOX15TSHRKDM4E
SCHEMBL29668566 0.83 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A
SCHEMBL16422282 0.83 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A
SCHEMBL14761667 0.83 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A
SCHEMBL20140095 0.83 HTR1A (0.54) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A
SCHEMBL29924612 0.83 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A
SCHEMBL16422799 0.83 GRM1 (0.41) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A
SCHEMBL17844401 0.82 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A
SCHEMBL5337565 0.81 GRM1 (0.58) GRM1GRM5NAMPTCNR1
SCHEMBL29924281 0.81 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2NPC1ALOX15RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113227068-A GLP-1R agonists and uses thereof 上海齐鲁锐格医药研发有限公司 2021-08-06 CN disclosed
US-8748420-B2 Pyridinylcarboxylic acid derivatives as fungicides BAYER CROPSCIENCE AG (DE) 2014-06-10 US disclosed
US-20140066442-A1 Pyridinylcarboxylic Acid Derivatives as Fungicides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-03-06 US disclosed
US-8604040-B2 Pyridinylcarboxylic acid derivatives as fungicides BAYER CROPSCIENCE AG (DE) 2013-12-10 US disclosed
US-8580802-B2 Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-11-12 US disclosed
EP-2532667-A1 Deazapurines useful as inhibitors of janus kinases Vertex Pharmaceuticals Incorporated (US) 2012-12-12 EP disclosed
EP-1931674-B1 DEAZAPURINES USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMA (US) 2012-12-12 EP disclosed
US-20120065197-A1 Pyridinylcarboxylic Acid Derivatives as Fungicides BAYER CROPSCIENCE AG (DE) 2012-03-15 US disclosed
US-20070207995-A1 Deazapurines useful as inhibitors of Janus kinases VERTEX PHARMACEUTICALS INCORPORATED 2007-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065197-A1 Pyridinylcarboxylic Acid Derivatives as Fungicides PNPO, CYP1A1, CHRM1 ALDH1A1 1009/4885SMN1; SMN2 3910/4885NPC1 3961/4885
US-20140066442-A1 Pyridinylcarboxylic Acid Derivatives as Fungicides PNPO, CYP1A1, CHRM1 ALDH1A1 1051/4885SMN1; SMN2 4075/4885NPC1 4008/4885
US-20070207995-A1 Deazapurines useful as inhibitors of Janus kinases JAK1, JAK3, JAK2 ALDH1A1 2028/4885SMN1; SMN2 3118/4885NPC1 3736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.